Pharma & Healthcare
Global Genito-Urinary Drugs Market Research Report 2025
- Sep 09, 25
- ID: 497314
- Pages: 85
- Figures: 84
- Views: 4
Report Scope
This report aims to provide a comprehensive presentation of the global market for Genito-Urinary Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genito-Urinary Drugs.
The Genito-Urinary Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Genito-Urinary Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genito-Urinary Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Daiichi Sankyo Company
Pfizer
Bayer
Astellas Pharma
AbbVie
GSK
Otsuka Pharmaceutical
Sanofi
Segment by Type
OTC
Rx Drugs
Segment by Application
Hospital
Drugs Store
Other
Consumption by Region
North America
the United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Genito-Urinary Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Genito-Urinary Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Genito-Urinary Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genito-Urinary Drugs.
The Genito-Urinary Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Genito-Urinary Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genito-Urinary Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Daiichi Sankyo Company
Pfizer
Bayer
Astellas Pharma
AbbVie
GSK
Otsuka Pharmaceutical
Sanofi
Segment by Type
OTC
Rx Drugs
Segment by Application
Hospital
Drugs Store
Other
Consumption by Region
North America
the United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Genito-Urinary Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Genito-Urinary Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Genito-Urinary Drugs Market Overview
1.1 Product Definition
1.2 Genito-Urinary Drugs by Type
1.2.1 Global Genito-Urinary Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Genito-Urinary Drugs by Application
1.3.1 Global Genito-Urinary Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Global Genito-Urinary Drugs Market Size Estimates and Forecasts
1.4.1 Global Genito-Urinary Drugs Revenue 2020-2031
1.4.2 Global Genito-Urinary Drugs Sales 2020-2031
1.4.3 Global Genito-Urinary Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Genito-Urinary Drugs Market Competition by Manufacturers
2.1 Global Genito-Urinary Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Genito-Urinary Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Genito-Urinary Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Genito-Urinary Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Genito-Urinary Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Genito-Urinary Drugs, Product Type & Application
2.7 Global Key Manufacturers of Genito-Urinary Drugs, Date of Enter into This Industry
2.8 Global Genito-Urinary Drugs Market Competitive Situation and Trends
2.8.1 Global Genito-Urinary Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Genito-Urinary Drugs Players Market Share by Revenue
2.8.3 Global Genito-Urinary Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Genito-Urinary Drugs Market Scenario by Region
3.1 Global Genito-Urinary Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Genito-Urinary Drugs Sales by Region: 2020-2031
3.2.1 Global Genito-Urinary Drugs Sales by Region: 2020-2025
3.2.2 Global Genito-Urinary Drugs Sales by Region: 2026-2031
3.3 Global Genito-Urinary Drugs Revenue by Region: 2020-2031
3.3.1 Global Genito-Urinary Drugs Revenue by Region: 2020-2025
3.3.2 Global Genito-Urinary Drugs Revenue by Region: 2026-2031
3.4 North America Genito-Urinary Drugs Market Facts & Figures by Country
3.4.1 North America Genito-Urinary Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Genito-Urinary Drugs Sales by Country (2020-2031)
3.4.3 North America Genito-Urinary Drugs Revenue by Country (2020-2031)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Genito-Urinary Drugs Market Facts & Figures by Country
3.5.1 Europe Genito-Urinary Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Genito-Urinary Drugs Sales by Country (2020-2031)
3.5.3 Europe Genito-Urinary Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Genito-Urinary Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Genito-Urinary Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Genito-Urinary Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Genito-Urinary Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Genito-Urinary Drugs Market Facts & Figures by Country
3.7.1 Latin America Genito-Urinary Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Genito-Urinary Drugs Sales by Country (2020-2031)
3.7.3 Latin America Genito-Urinary Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Genito-Urinary Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Genito-Urinary Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Genito-Urinary Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Genito-Urinary Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Genito-Urinary Drugs Sales by Type (2020-2031)
4.1.1 Global Genito-Urinary Drugs Sales by Type (2020-2025)
4.1.2 Global Genito-Urinary Drugs Sales by Type (2026-2031)
4.1.3 Global Genito-Urinary Drugs Sales Market Share by Type (2020-2031)
4.2 Global Genito-Urinary Drugs Revenue by Type (2020-2031)
4.2.1 Global Genito-Urinary Drugs Revenue by Type (2020-2025)
4.2.2 Global Genito-Urinary Drugs Revenue by Type (2026-2031)
4.2.3 Global Genito-Urinary Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Genito-Urinary Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Genito-Urinary Drugs Sales by Application (2020-2031)
5.1.1 Global Genito-Urinary Drugs Sales by Application (2020-2025)
5.1.2 Global Genito-Urinary Drugs Sales by Application (2026-2031)
5.1.3 Global Genito-Urinary Drugs Sales Market Share by Application (2020-2031)
5.2 Global Genito-Urinary Drugs Revenue by Application (2020-2031)
5.2.1 Global Genito-Urinary Drugs Revenue by Application (2020-2025)
5.2.2 Global Genito-Urinary Drugs Revenue by Application (2026-2031)
5.2.3 Global Genito-Urinary Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Genito-Urinary Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Daiichi Sankyo Company
6.1.1 Daiichi Sankyo Company Company Information
6.1.2 Daiichi Sankyo Company Description and Business Overview
6.1.3 Daiichi Sankyo Company Genito-Urinary Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Daiichi Sankyo Company Genito-Urinary Drugs Product Portfolio
6.1.5 Daiichi Sankyo Company Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Genito-Urinary Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Genito-Urinary Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Company Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Genito-Urinary Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bayer Genito-Urinary Drugs Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Astellas Pharma
6.4.1 Astellas Pharma Company Information
6.4.2 Astellas Pharma Description and Business Overview
6.4.3 Astellas Pharma Genito-Urinary Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Astellas Pharma Genito-Urinary Drugs Product Portfolio
6.4.5 Astellas Pharma Recent Developments/Updates
6.5 AbbVie
6.5.1 AbbVie Company Information
6.5.2 AbbVie Description and Business Overview
6.5.3 AbbVie Genito-Urinary Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 AbbVie Genito-Urinary Drugs Product Portfolio
6.5.5 AbbVie Recent Developments/Updates
6.6 GSK
6.6.1 GSK Company Information
6.6.2 GSK Description and Business Overview
6.6.3 GSK Genito-Urinary Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GSK Genito-Urinary Drugs Product Portfolio
6.6.5 GSK Recent Developments/Updates
6.7 Otsuka Pharmaceutical
6.7.1 Otsuka Pharmaceutical Company Information
6.7.2 Otsuka Pharmaceutical Description and Business Overview
6.7.3 Otsuka Pharmaceutical Genito-Urinary Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Otsuka Pharmaceutical Genito-Urinary Drugs Product Portfolio
6.7.5 Otsuka Pharmaceutical Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Company Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Genito-Urinary Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sanofi Genito-Urinary Drugs Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Genito-Urinary Drugs Industry Chain Analysis
7.2 Genito-Urinary Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Genito-Urinary Drugs Production Mode & Process Analysis
7.4 Genito-Urinary Drugs Sales and Marketing
7.4.1 Genito-Urinary Drugs Sales Channels
7.4.2 Genito-Urinary Drugs Distributors
7.5 Genito-Urinary Drugs Customer Analysis
8 Genito-Urinary Drugs Market Dynamics
8.1 Genito-Urinary Drugs Industry Trends
8.2 Genito-Urinary Drugs Market Drivers
8.3 Genito-Urinary Drugs Market Challenges
8.4 Genito-Urinary Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Genito-Urinary Drugs by Type
1.2.1 Global Genito-Urinary Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Genito-Urinary Drugs by Application
1.3.1 Global Genito-Urinary Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Global Genito-Urinary Drugs Market Size Estimates and Forecasts
1.4.1 Global Genito-Urinary Drugs Revenue 2020-2031
1.4.2 Global Genito-Urinary Drugs Sales 2020-2031
1.4.3 Global Genito-Urinary Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Genito-Urinary Drugs Market Competition by Manufacturers
2.1 Global Genito-Urinary Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Genito-Urinary Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Genito-Urinary Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Genito-Urinary Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Genito-Urinary Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Genito-Urinary Drugs, Product Type & Application
2.7 Global Key Manufacturers of Genito-Urinary Drugs, Date of Enter into This Industry
2.8 Global Genito-Urinary Drugs Market Competitive Situation and Trends
2.8.1 Global Genito-Urinary Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Genito-Urinary Drugs Players Market Share by Revenue
2.8.3 Global Genito-Urinary Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Genito-Urinary Drugs Market Scenario by Region
3.1 Global Genito-Urinary Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Genito-Urinary Drugs Sales by Region: 2020-2031
3.2.1 Global Genito-Urinary Drugs Sales by Region: 2020-2025
3.2.2 Global Genito-Urinary Drugs Sales by Region: 2026-2031
3.3 Global Genito-Urinary Drugs Revenue by Region: 2020-2031
3.3.1 Global Genito-Urinary Drugs Revenue by Region: 2020-2025
3.3.2 Global Genito-Urinary Drugs Revenue by Region: 2026-2031
3.4 North America Genito-Urinary Drugs Market Facts & Figures by Country
3.4.1 North America Genito-Urinary Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Genito-Urinary Drugs Sales by Country (2020-2031)
3.4.3 North America Genito-Urinary Drugs Revenue by Country (2020-2031)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Genito-Urinary Drugs Market Facts & Figures by Country
3.5.1 Europe Genito-Urinary Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Genito-Urinary Drugs Sales by Country (2020-2031)
3.5.3 Europe Genito-Urinary Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Genito-Urinary Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Genito-Urinary Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Genito-Urinary Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Genito-Urinary Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Genito-Urinary Drugs Market Facts & Figures by Country
3.7.1 Latin America Genito-Urinary Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Genito-Urinary Drugs Sales by Country (2020-2031)
3.7.3 Latin America Genito-Urinary Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Genito-Urinary Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Genito-Urinary Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Genito-Urinary Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Genito-Urinary Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Genito-Urinary Drugs Sales by Type (2020-2031)
4.1.1 Global Genito-Urinary Drugs Sales by Type (2020-2025)
4.1.2 Global Genito-Urinary Drugs Sales by Type (2026-2031)
4.1.3 Global Genito-Urinary Drugs Sales Market Share by Type (2020-2031)
4.2 Global Genito-Urinary Drugs Revenue by Type (2020-2031)
4.2.1 Global Genito-Urinary Drugs Revenue by Type (2020-2025)
4.2.2 Global Genito-Urinary Drugs Revenue by Type (2026-2031)
4.2.3 Global Genito-Urinary Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Genito-Urinary Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Genito-Urinary Drugs Sales by Application (2020-2031)
5.1.1 Global Genito-Urinary Drugs Sales by Application (2020-2025)
5.1.2 Global Genito-Urinary Drugs Sales by Application (2026-2031)
5.1.3 Global Genito-Urinary Drugs Sales Market Share by Application (2020-2031)
5.2 Global Genito-Urinary Drugs Revenue by Application (2020-2031)
5.2.1 Global Genito-Urinary Drugs Revenue by Application (2020-2025)
5.2.2 Global Genito-Urinary Drugs Revenue by Application (2026-2031)
5.2.3 Global Genito-Urinary Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Genito-Urinary Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Daiichi Sankyo Company
6.1.1 Daiichi Sankyo Company Company Information
6.1.2 Daiichi Sankyo Company Description and Business Overview
6.1.3 Daiichi Sankyo Company Genito-Urinary Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Daiichi Sankyo Company Genito-Urinary Drugs Product Portfolio
6.1.5 Daiichi Sankyo Company Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Genito-Urinary Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Genito-Urinary Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Company Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Genito-Urinary Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bayer Genito-Urinary Drugs Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Astellas Pharma
6.4.1 Astellas Pharma Company Information
6.4.2 Astellas Pharma Description and Business Overview
6.4.3 Astellas Pharma Genito-Urinary Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Astellas Pharma Genito-Urinary Drugs Product Portfolio
6.4.5 Astellas Pharma Recent Developments/Updates
6.5 AbbVie
6.5.1 AbbVie Company Information
6.5.2 AbbVie Description and Business Overview
6.5.3 AbbVie Genito-Urinary Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 AbbVie Genito-Urinary Drugs Product Portfolio
6.5.5 AbbVie Recent Developments/Updates
6.6 GSK
6.6.1 GSK Company Information
6.6.2 GSK Description and Business Overview
6.6.3 GSK Genito-Urinary Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GSK Genito-Urinary Drugs Product Portfolio
6.6.5 GSK Recent Developments/Updates
6.7 Otsuka Pharmaceutical
6.7.1 Otsuka Pharmaceutical Company Information
6.7.2 Otsuka Pharmaceutical Description and Business Overview
6.7.3 Otsuka Pharmaceutical Genito-Urinary Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Otsuka Pharmaceutical Genito-Urinary Drugs Product Portfolio
6.7.5 Otsuka Pharmaceutical Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Company Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Genito-Urinary Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sanofi Genito-Urinary Drugs Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Genito-Urinary Drugs Industry Chain Analysis
7.2 Genito-Urinary Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Genito-Urinary Drugs Production Mode & Process Analysis
7.4 Genito-Urinary Drugs Sales and Marketing
7.4.1 Genito-Urinary Drugs Sales Channels
7.4.2 Genito-Urinary Drugs Distributors
7.5 Genito-Urinary Drugs Customer Analysis
8 Genito-Urinary Drugs Market Dynamics
8.1 Genito-Urinary Drugs Industry Trends
8.2 Genito-Urinary Drugs Market Drivers
8.3 Genito-Urinary Drugs Market Challenges
8.4 Genito-Urinary Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Genito-Urinary Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Genito-Urinary Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Genito-Urinary Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Genito-Urinary Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Genito-Urinary Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Genito-Urinary Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Genito-Urinary Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Genito-Urinary Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Genito-Urinary Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Genito-Urinary Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Genito-Urinary Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Genito-Urinary Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Genito-Urinary Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genito-Urinary Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Genito-Urinary Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Genito-Urinary Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Genito-Urinary Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Genito-Urinary Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Genito-Urinary Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Genito-Urinary Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Genito-Urinary Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Genito-Urinary Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Genito-Urinary Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Genito-Urinary Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Genito-Urinary Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Genito-Urinary Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Genito-Urinary Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Genito-Urinary Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Genito-Urinary Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Genito-Urinary Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Genito-Urinary Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Genito-Urinary Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Genito-Urinary Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Genito-Urinary Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Genito-Urinary Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Genito-Urinary Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Genito-Urinary Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Genito-Urinary Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Genito-Urinary Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Genito-Urinary Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Genito-Urinary Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Genito-Urinary Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Genito-Urinary Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Genito-Urinary Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Genito-Urinary Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Genito-Urinary Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Genito-Urinary Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Genito-Urinary Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Genito-Urinary Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Genito-Urinary Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Genito-Urinary Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Genito-Urinary Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Genito-Urinary Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Genito-Urinary Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Genito-Urinary Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Genito-Urinary Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Genito-Urinary Drugs Price (USD/Unit) by Type (2020-2025)
Table 59. Global Genito-Urinary Drugs Price (USD/Unit) by Type (2026-2031)
Table 60. Global Genito-Urinary Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Genito-Urinary Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Genito-Urinary Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Genito-Urinary Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Genito-Urinary Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Genito-Urinary Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Genito-Urinary Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Genito-Urinary Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Genito-Urinary Drugs Price (USD/Unit) by Application (2020-2025)
Table 69. Global Genito-Urinary Drugs Price (USD/Unit) by Application (2026-2031)
Table 70. Daiichi Sankyo Company Company Information
Table 71. Daiichi Sankyo Company Description and Business Overview
Table 72. Daiichi Sankyo Company Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Daiichi Sankyo Company Genito-Urinary Drugs Product
Table 74. Daiichi Sankyo Company Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Pfizer Genito-Urinary Drugs Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Bayer Company Information
Table 81. Bayer Description and Business Overview
Table 82. Bayer Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Bayer Genito-Urinary Drugs Product
Table 84. Bayer Recent Developments/Updates
Table 85. Astellas Pharma Company Information
Table 86. Astellas Pharma Description and Business Overview
Table 87. Astellas Pharma Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Astellas Pharma Genito-Urinary Drugs Product
Table 89. Astellas Pharma Recent Developments/Updates
Table 90. AbbVie Company Information
Table 91. AbbVie Description and Business Overview
Table 92. AbbVie Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. AbbVie Genito-Urinary Drugs Product
Table 94. AbbVie Recent Developments/Updates
Table 95. GSK Company Information
Table 96. GSK Description and Business Overview
Table 97. GSK Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. GSK Genito-Urinary Drugs Product
Table 99. GSK Recent Developments/Updates
Table 100. Otsuka Pharmaceutical Company Information
Table 101. Otsuka Pharmaceutical Description and Business Overview
Table 102. Otsuka Pharmaceutical Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Otsuka Pharmaceutical Genito-Urinary Drugs Product
Table 104. Otsuka Pharmaceutical Recent Developments/Updates
Table 105. Sanofi Company Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Sanofi Genito-Urinary Drugs Product
Table 109. Sanofi Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Genito-Urinary Drugs Distributors List
Table 113. Genito-Urinary Drugs Customers List
Table 114. Genito-Urinary Drugs Market Trends
Table 115. Genito-Urinary Drugs Market Drivers
Table 116. Genito-Urinary Drugs Market Challenges
Table 117. Genito-Urinary Drugs Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Genito-Urinary Drugs
Figure 2. Global Genito-Urinary Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Genito-Urinary Drugs Market Share by Type: 2024 & 2031
Figure 4. OTC Product Picture
Figure 5. Rx Drugs Product Picture
Figure 6. Global Genito-Urinary Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Genito-Urinary Drugs Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Drugs Store
Figure 10. Other
Figure 11. Global Genito-Urinary Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Genito-Urinary Drugs Market Size (2020-2031) & (US$ Million)
Figure 13. Global Genito-Urinary Drugs Sales (2020-2031) & (K Units)
Figure 14. Global Genito-Urinary Drugs Average Price (USD/Unit) & (2020-2031)
Figure 15. Genito-Urinary Drugs Report Years Considered
Figure 16. Genito-Urinary Drugs Sales Share by Manufacturers in 2024
Figure 17. Global Genito-Urinary Drugs Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Genito-Urinary Drugs Players: Market Share by Revenue in Genito-Urinary Drugs in 2024
Figure 19. Genito-Urinary Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Genito-Urinary Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Genito-Urinary Drugs Sales Market Share by Country (2020-2031)
Figure 22. North America Genito-Urinary Drugs Revenue Market Share by Country (2020-2031)
Figure 23. the United States Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Genito-Urinary Drugs Sales Market Share by Country (2020-2031)
Figure 26. Europe Genito-Urinary Drugs Revenue Market Share by Country (2020-2031)
Figure 27. Germany Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. UK Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Genito-Urinary Drugs Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Genito-Urinary Drugs Revenue Market Share by Region (2020-2031)
Figure 34. China Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Genito-Urinary Drugs Sales Market Share by Country (2020-2031)
Figure 44. Latin America Genito-Urinary Drugs Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Genito-Urinary Drugs Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Genito-Urinary Drugs Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Genito-Urinary Drugs by Type (2020-2031)
Figure 54. Global Revenue Market Share of Genito-Urinary Drugs by Type (2020-2031)
Figure 55. Global Genito-Urinary Drugs Price (USD/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Genito-Urinary Drugs by Application (2020-2031)
Figure 57. Global Revenue Market Share of Genito-Urinary Drugs by Application (2020-2031)
Figure 58. Global Genito-Urinary Drugs Price (USD/Unit) by Application (2020-2031)
Figure 59. Genito-Urinary Drugs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Genito-Urinary Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Genito-Urinary Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Genito-Urinary Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Genito-Urinary Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Genito-Urinary Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Genito-Urinary Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Genito-Urinary Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Genito-Urinary Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Genito-Urinary Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Genito-Urinary Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Genito-Urinary Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Genito-Urinary Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Genito-Urinary Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genito-Urinary Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Genito-Urinary Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Genito-Urinary Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Genito-Urinary Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Genito-Urinary Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Genito-Urinary Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Genito-Urinary Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Genito-Urinary Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Genito-Urinary Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Genito-Urinary Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Genito-Urinary Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Genito-Urinary Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Genito-Urinary Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Genito-Urinary Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Genito-Urinary Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Genito-Urinary Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Genito-Urinary Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Genito-Urinary Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Genito-Urinary Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Genito-Urinary Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Genito-Urinary Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Genito-Urinary Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Genito-Urinary Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Genito-Urinary Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Genito-Urinary Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Genito-Urinary Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Genito-Urinary Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Genito-Urinary Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Genito-Urinary Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Genito-Urinary Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Genito-Urinary Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Genito-Urinary Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Genito-Urinary Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Genito-Urinary Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Genito-Urinary Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Genito-Urinary Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Genito-Urinary Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Genito-Urinary Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Genito-Urinary Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Genito-Urinary Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Genito-Urinary Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Genito-Urinary Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Genito-Urinary Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Genito-Urinary Drugs Price (USD/Unit) by Type (2020-2025)
Table 59. Global Genito-Urinary Drugs Price (USD/Unit) by Type (2026-2031)
Table 60. Global Genito-Urinary Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Genito-Urinary Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Genito-Urinary Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Genito-Urinary Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Genito-Urinary Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Genito-Urinary Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Genito-Urinary Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Genito-Urinary Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Genito-Urinary Drugs Price (USD/Unit) by Application (2020-2025)
Table 69. Global Genito-Urinary Drugs Price (USD/Unit) by Application (2026-2031)
Table 70. Daiichi Sankyo Company Company Information
Table 71. Daiichi Sankyo Company Description and Business Overview
Table 72. Daiichi Sankyo Company Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Daiichi Sankyo Company Genito-Urinary Drugs Product
Table 74. Daiichi Sankyo Company Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Pfizer Genito-Urinary Drugs Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Bayer Company Information
Table 81. Bayer Description and Business Overview
Table 82. Bayer Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Bayer Genito-Urinary Drugs Product
Table 84. Bayer Recent Developments/Updates
Table 85. Astellas Pharma Company Information
Table 86. Astellas Pharma Description and Business Overview
Table 87. Astellas Pharma Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Astellas Pharma Genito-Urinary Drugs Product
Table 89. Astellas Pharma Recent Developments/Updates
Table 90. AbbVie Company Information
Table 91. AbbVie Description and Business Overview
Table 92. AbbVie Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. AbbVie Genito-Urinary Drugs Product
Table 94. AbbVie Recent Developments/Updates
Table 95. GSK Company Information
Table 96. GSK Description and Business Overview
Table 97. GSK Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. GSK Genito-Urinary Drugs Product
Table 99. GSK Recent Developments/Updates
Table 100. Otsuka Pharmaceutical Company Information
Table 101. Otsuka Pharmaceutical Description and Business Overview
Table 102. Otsuka Pharmaceutical Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Otsuka Pharmaceutical Genito-Urinary Drugs Product
Table 104. Otsuka Pharmaceutical Recent Developments/Updates
Table 105. Sanofi Company Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Sanofi Genito-Urinary Drugs Product
Table 109. Sanofi Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Genito-Urinary Drugs Distributors List
Table 113. Genito-Urinary Drugs Customers List
Table 114. Genito-Urinary Drugs Market Trends
Table 115. Genito-Urinary Drugs Market Drivers
Table 116. Genito-Urinary Drugs Market Challenges
Table 117. Genito-Urinary Drugs Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Genito-Urinary Drugs
Figure 2. Global Genito-Urinary Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Genito-Urinary Drugs Market Share by Type: 2024 & 2031
Figure 4. OTC Product Picture
Figure 5. Rx Drugs Product Picture
Figure 6. Global Genito-Urinary Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Genito-Urinary Drugs Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Drugs Store
Figure 10. Other
Figure 11. Global Genito-Urinary Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Genito-Urinary Drugs Market Size (2020-2031) & (US$ Million)
Figure 13. Global Genito-Urinary Drugs Sales (2020-2031) & (K Units)
Figure 14. Global Genito-Urinary Drugs Average Price (USD/Unit) & (2020-2031)
Figure 15. Genito-Urinary Drugs Report Years Considered
Figure 16. Genito-Urinary Drugs Sales Share by Manufacturers in 2024
Figure 17. Global Genito-Urinary Drugs Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Genito-Urinary Drugs Players: Market Share by Revenue in Genito-Urinary Drugs in 2024
Figure 19. Genito-Urinary Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Genito-Urinary Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Genito-Urinary Drugs Sales Market Share by Country (2020-2031)
Figure 22. North America Genito-Urinary Drugs Revenue Market Share by Country (2020-2031)
Figure 23. the United States Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Genito-Urinary Drugs Sales Market Share by Country (2020-2031)
Figure 26. Europe Genito-Urinary Drugs Revenue Market Share by Country (2020-2031)
Figure 27. Germany Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. UK Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Genito-Urinary Drugs Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Genito-Urinary Drugs Revenue Market Share by Region (2020-2031)
Figure 34. China Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Genito-Urinary Drugs Sales Market Share by Country (2020-2031)
Figure 44. Latin America Genito-Urinary Drugs Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Genito-Urinary Drugs Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Genito-Urinary Drugs Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Genito-Urinary Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Genito-Urinary Drugs by Type (2020-2031)
Figure 54. Global Revenue Market Share of Genito-Urinary Drugs by Type (2020-2031)
Figure 55. Global Genito-Urinary Drugs Price (USD/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Genito-Urinary Drugs by Application (2020-2031)
Figure 57. Global Revenue Market Share of Genito-Urinary Drugs by Application (2020-2031)
Figure 58. Global Genito-Urinary Drugs Price (USD/Unit) by Application (2020-2031)
Figure 59. Genito-Urinary Drugs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232